WinstonWınston
Vicarious Surgical logo

Vicarious Surgical

RBOT
Medical - Devices · Healthcare
Price
$0.07
+0.00 (+0.00%)
Market Cap
$433,983
Exchange
Other OTC
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+84.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 3.2M (2021) → 5.9M (2025)

Vicarious Surgical is a medical robotics company that is developing a miniaturized surgical robot designed to perform minimally invasive abdominal surgeries. The system uses tiny cameras and robotic arms that can be inserted through a single small incision, giving surgeons a virtual reality-like view inside the patient's body. The company's target customers are hospitals and surgeons performing soft-tissue procedures.

The company earns no meaningful revenue yet and is in the pre-commercial development stage, which explains its deeply negative margins and return on capital. Vicarious Surgical is based in the United States and has a very small market capitalization, competing in a space dominated by Intuitive Surgical, which makes the widely used da Vinci robot. The key risk is that the company must successfully complete regulatory clearance from the FDA and prove its system is safe and effective before it can generate sales — a process that requires significant ongoing cash burn with no guarantee of success.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+58.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$34M/ year

Declining (-16% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

35.8%ownership

Insiders own a meaningful stake in the company

Cash Runway

~2 months

$4M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Short runway — potential dilution ahead through share issuance

Cash watch

Vicarious Surgical has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
Data not available
Operating Margin
N/A
Data not available
ROCE
-78.1%
Weak — -78.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
Data not available
EPS YoY
N/A
Data not available
EPS Consistency
7/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
1.69
Elevated debt (1.69)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial